Page last updated: 2024-11-05

diphenyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

diphenyl: RN given refers to unlabeled cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
CitrusgenusA plant genus of the family RUTACEAE. They bear the familiar citrus fruits including oranges, grapefruit, lemons, and limes. There are many hybrids which makes the nomenclature confusing.[MeSH]RutaceaeA plant family in the order Sapindales that grows in warmer regions and has conspicuous flowers.[MeSH]

Cross-References

ID SourceID
PubMed CID7095
CHEMBL ID14092
CHEBI ID17097
MeSH IDM0056156

Synonyms (97)

Synonym
BIDD:ER0669
CHEBI:17097 ,
e230
ccris 935
fema no. 3129
carolid al
epa pesticide chemical code 017002
mcs 1572
cp 390
tetrosin ly
einecs 202-163-5
biphenyl [bsi:iso]
ai3-00036
nsc 14916
hsdb 530
caswell no. 087
phenador-x
nsc14916
xenene
phph
nsc-14916
lemonene
diphenyl
bibenzene
wln: rr
inchi=1/c12h10/c1-3-7-11(8-4-1)12-9-5-2-6-10-12/h1-10
NCGC00091836-01
1,1'-biphenyl
92-52-4
phenylbenzene
biphenyl ,
1,1'-diphenyl
C06588
biphenyl, analytical standard
biphenyl, reagentplus(r), 99.5%
biphenyl, >=99%
BNL ,
NCGC00091836-02
68409-73-4
1,1-biphenyl
diphenyl, 14c-labeled
B0465
B0224
BMSE000506
CHEMBL14092 ,
1,1''-biphenyl
bdbm50168002
AKOS000119944
NCGC00091836-04
NCGC00091836-03
NCGC00259657-01
tox21_300167
dtxsid4020161 ,
NCGC00254175-01
dtxcid60161
tox21_202108
cas-92-52-4
2l9gjk6mgn ,
ec 202-163-5
unii-2l9gjk6mgn
FT-0602830
STL264192
biphenyl [hsdb]
diphenyl [mi]
e-230
ins-230
biphenyl [fhfi]
biphenyl [usp-rs]
ins no.230
biphenyl [iso]
diphenyl [mart.]
4,4'-biphenyl
bi-phenyl
meta biphenyl
diphenyl-4-d1
4819-98-1
W-100283
diphenyl-4,4'-d2
6120-99-6
F9995-1632
mfcd00003054
biphenyl, certified reference material, tracecert(r)
biphenyl, pestanal(r), analytical standard
biphenyl, united states pharmacopeia (usp) reference standard
biphenyl, vetec(tm) reagent grade, 99%
biphenyl 100 microg/ml in methanol
biphenyl 10 microg/ml in cyclohexane
1,1'-biphenyl, 9ci
biphenyl-ul-14c
1, 1'-diphenyl
fema 3129
diphenyl,(s)
Q410915
EN300-18009
4-biphenyl
BS-42211
26008-28-6

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Diphenyl pyrimidine treatment inhibited histopathological changes in S."( Diphenyl pyrimidine exhibits protective effect on Staphylococcus aureus pneumonia in rat model by targeting NLRP3 expression.
Dai, Y; Duan, W; Qin, F; Wu, D, 2021
)
2.79

Toxicity

2-ethylhexyl diphenyl phosphate (EHDPHP) is a frequently detected organophosphate ester in various environmental media. The toxic effects of EHDPHP on aquatic organisms of different sexes remain unclear.

ExcerptReferenceRelevance
" DP caused genetic effects in yeast with and without activating system, while the two chemicals appeared to be ineffective in Salmonella up to toxic levels."( Genotoxicity and teratogenicity of diphenyl and diphenyl ether: a study of sea urchins, yeast, and Salmonella typhimurium.
Bauer, C; Bronzetti, G; Ciajolo, A; Corsi, C; Esposito, A; Giordano, GG; Nieri, R; Pagano, G; Quinto, I; Vamvakinos, E, 1983
)
0.54
" OPP-epoxide and BP were less toxic than the OPP isomers."( Cytotoxic effects of biphenyl and hydroxybiphenyls on isolated rat hepatocytes.
Moldéus, P; Moore, G; Nakagawa, Y; Tayama, S, 1993
)
0.29
" While multiple exposure is widely acknowledged, arguments are raised that adverse combined effects might not be evoked by mixtures of substances with dissimilar modes of action and being present at only low concentrations."( Mixture toxicity of priority pollutants at no observed effect concentrations (NOECs).
Altenburger, R; Consolaro, F; Gramatica, P; Scholze, M; Walter, H, 2002
)
0.31
" Acute exposure to high levels of biphenyl has been observed to cause skin irritation and toxic effects on the liver and kidneys."( Biphenyl-induced cytotoxicity is mediated by an increase in intracellular Zn
Abe, S; Ae, M; Imura, N; Inubushi, T; Kamemura, N; Sugimoto, M; Yusuke, B, 2019
)
0.51
"As a frequently detected organophosphate ester in various environmental media, the toxic effects of 2-ethylhexyl diphenyl phosphate (EHDPHP) on aquatic organisms of different sexes remain unclear."( Insights into the sex-dependent reproductive toxicity of 2-ethylhexyl diphenyl phosphate on zebrafish (Danio rerio).
Chen, P; Liu, Q; Wang, J; Wang, X; Yang, R; Zhong, W; Zhu, L, 2022
)
1.17
" In order to investigate the specific toxic effects of 2-ethylhexyl diphenyl phosphate (EHDPHP) exposure on chickens and the molecular biological mechanisms that cause damage to the organism, the chicken liver has been studied as a potential target organ for toxic effects."( Oxidative stress and ferroptosis involved in 2-ethylhexyl diphenyl phosphate -induced hepatotoxicity in chicken.
Chen, J; Ge, M; Li, G; Li, J; Wang, X; Yang, Y; Yu, M; Zhang, H; Zhang, R, 2022
)
1.2

Pharmacokinetics

ExcerptReferenceRelevance
" These structureproperty relationships should be taken into account in the pharmacokinetic optimization of new series of H3 receptor antagonists."( Brain pharmacokinetics of non-imidazole biphenyl H3 receptor antagonists: a liquid chromatography/electrospray-mass spectrometry and ex vivo binding study in rats.
Ballabeni, V; Barocelli, E; Flammini, L; Mor, M; Silva, C; Vacondio, F, 2012
)
0.38
" The optimized NSs (B-CDN3) was further confirmed by SEM, spectral analysis, BET analysis, in vitro release and pharmacokinetic studies."( Development of Diphenyl carbonate-Crosslinked Cyclodextrin Based Nanosponges for Oral Delivery of Baricitinib: Formulation, Characterization and Pharmacokinetic Studies.
Ahmed, MM; Aldawsari, MF; Alhowail, AH; Anwer, MK, 2023
)
1.26

Bioavailability

ExcerptReferenceRelevance
" Biodegradation was also related to bioavailability of the substrate."( Factors affecting PCB degradation by an implanted bacterial strain in soil microcosms.
Barriault, D; Sylvestre, M, 1993
)
0.29
" The problem of bioavailability of aromatic compounds in cell culture assays and the relation to lipophilicity was addressed."( Biologic testing of leachable aromatic compounds from denture base materials.
Gjerdet, NR; Lygre, H; Moe, G; Solheim, E, 1995
)
0.29
" There are few studies that have tested the effects of long-term aging on chemical dynamics in soils and have related these effects to bioavailability tests of these aged compounds."( Effects of aging on the bioavailability and sorption/desorption behavior of biphenyl in soils.
Boyd, SA; Chung, SY; Feng, Y; Park, JH; Sharer, M; Voice, TC, 2005
)
0.33
"A novel class of biphenyl analogues containing a benzoic acid moiety based on lead compound 8i have been identified as potent and selective human beta 3 adrenergic receptor (beta 3-AR) agonists with good oral bioavailability and long plasma half-life."( Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part I.
Hamada, K; Hamashima, H; Hattori, K; Imamura, E; Imanishi, M; Ishikawa, H; Itou, S; Matsui, S; Matsumura, Y; Nakajima, Y; Nakano, K; Sakurai, M; Takamura, F; Tomishima, Y; Ueshima, K; Unami, N; Washizuka, K; Yamamoto, N; Yamamoto, T, 2008
)
0.35
" It was concluded that high PCB degradation was due to the increased PCB bioavailability as well as biostimulation of microbial communities after plantation and beta-cyclodextrin addition."( Beta-cyclodextrin enhanced phytoremediation of aged PCBs-contaminated soil from e-waste recycling area.
Cheema, SA; Chen, Y; Liu, W; Shen, C; Tang, X, 2010
)
0.36
" Methyl ester 20 has promising oral bioavailability and pharmacokinetics and may target 5-HT4 receptors in both CNS and peripheral organs."( Acidic biphenyl derivatives: synthesis and biological activity of a new series of potent 5-HT(4) receptor antagonists.
Andressen, KW; Brudeli, B; Klaveness, J; Levy, FO; Moltzau, LR; Nilsen, NO, 2013
)
0.39
"A novel, potent, and orally bioavailable inhibitor of the bromodomain of CBP, compound 35 (GNE-207), has been identified through SAR investigations focused on optimizing al bicyclic heteroarene to replace the aniline present in the published GNE-272 series."( Design and synthesis of a biaryl series as inhibitors for the bromodomains of CBP/P300.
Beresini, MH; Bronner, SM; Chen, K; Chen, Z; Choo, EF; Crawford, TD; Cyr, P; de Leon Boenig, G; Kaufman, S; Lai, KW; Li, Y; Liao, J; Liu, W; Ly, J; Magnuson, S; Murray, J; Romero, FA; Shen, W; Tsui, V; Wai, J; Wang, F; Zhu, C; Zhu, X, 2018
)
0.48
"13 times enhancement in bioavailability in comparison to pure BAR suspension."( Development of Diphenyl carbonate-Crosslinked Cyclodextrin Based Nanosponges for Oral Delivery of Baricitinib: Formulation, Characterization and Pharmacokinetic Studies.
Ahmed, MM; Aldawsari, MF; Alhowail, AH; Anwer, MK, 2023
)
1.26
"It could be anticipated that NSs loaded with BAR as a promising tool for release and bioavailability for the treatment of rheumatic arthritis and Covid-19."( Development of Diphenyl carbonate-Crosslinked Cyclodextrin Based Nanosponges for Oral Delivery of Baricitinib: Formulation, Characterization and Pharmacokinetic Studies.
Ahmed, MM; Aldawsari, MF; Alhowail, AH; Anwer, MK, 2023
)
1.26

Dosage Studied

ExcerptRelevanceReference
" The 3-methylcholanthrene-dependent increases in 2- and 3-hydroxylation appear due to induction of a single form of cytochrome P-450, as indicated by similar dose-response relationships and similar changes in sensitivity to the inhibitors."( Biphenyl metabolism by rat liver microsomes: regioselective effects of inducers, inhibitors, and solvents.
Haugen, DA,
)
0.13
" The most active compounds 5b and e gave 3/4 cures on an IP dosage of 20 mg/kg."( Dicationic near-linear biphenyl benzimidazole derivatives as DNA-targeted antiprotozoal agents.
Batista-Parra, A; Boykin, DW; Brun, R; Ismail, MA; Miao, Y; Wenzler, T; Wilson, WD, 2005
)
0.33
" Biphenyl at concentration of 1500 mg/L was almost completely degraded in 24 h using SRpf at a dosage of 15% (v/v)."( A novel approach to stimulate the biphenyl-degrading potential of bacterial community from PCBs-contaminated soil of e-waste recycling sites.
Ding, L; Shen, C; Shen, H; Su, X; Yao, X; Yu, C, 2013
)
0.39
"8 % at a dosage of 10 % EOM (v/v), whereas the degradation efficiencies of control group (with inactivated EOM addition) and blank group (with lactate minimal medium) were only 21."( Enhanced degradation of biphenyl from PCB-contaminated sediments: the impact of extracellular organic matter from Micrococcus luteus.
Ding, L; Hashmi, MZ; Hu, J; Shen, C; Su, X; Zhang, Q, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antimicrobial food preservativeA food preservative which prevents decomposition of food by preventing the growth of fungi or bacteria. In European countries, E-numbers for permitted food preservatives are from E200 to E299, divided into sorbates (E200-209), benzoates (E210-219), sulfites (E220-229), phenols and formates (E230-239), nitrates (E240-259), acetates (E260-269), lactates (E270-279), propionates (E280-289) and others (E290-299).
antifungal agrochemicalAny substance used in acriculture, horticulture, forestry, etc. for its fungicidal properties.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
biphenylsBenzenoid aromatic compounds containing two phenyl or substituted-phenyl groups which are joined together by a single bond.
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
aromatic fungicideAn organic aromatic compound that has been used as a fungicide.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
biphenyl degradation212

Protein Targets (15)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency4.46680.003245.467312,589.2998AID2517
GLI family zinc finger 3Homo sapiens (human)Potency1.92430.000714.592883.7951AID1259369; AID1259392
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
progesterone receptorHomo sapiens (human)Potency27.30600.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency59.12000.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency35.48130.000817.505159.3239AID588544
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency109.49790.001530.607315,848.9004AID1224848; AID1224849
estrogen nuclear receptor alphaHomo sapiens (human)Potency12.76170.000229.305416,493.5996AID743075; AID743079
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency55.47250.057821.109761.2679AID1159526
potassium voltage-gated channel subfamily H member 2 isoform dHomo sapiens (human)Potency44.66840.01789.637444.6684AID588834
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency77.66370.000323.4451159.6830AID743065
heat shock protein beta-1Homo sapiens (human)Potency57.11590.042027.378961.6448AID743210; AID743228
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency54.48270.000627.21521,122.0200AID651741
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 1A2Homo sapiens (human)IC50 (µMol)160.00000.00011.774010.0000AID241334
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TransthyretinHomo sapiens (human)Concentration0.10000.01000.13800.6000AID161428
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (26)

Processvia Protein(s)Taxonomy
signal transductionTransthyretinHomo sapiens (human)
purine nucleobase metabolic processTransthyretinHomo sapiens (human)
steroid catabolic processCytochrome P450 1A2Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A2Homo sapiens (human)
cholesterol metabolic processCytochrome P450 1A2Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A2Homo sapiens (human)
toxin biosynthetic processCytochrome P450 1A2Homo sapiens (human)
post-embryonic developmentCytochrome P450 1A2Homo sapiens (human)
alkaloid metabolic processCytochrome P450 1A2Homo sapiens (human)
regulation of gene expressionCytochrome P450 1A2Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 1A2Homo sapiens (human)
dibenzo-p-dioxin metabolic processCytochrome P450 1A2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
lung developmentCytochrome P450 1A2Homo sapiens (human)
methylationCytochrome P450 1A2Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 1A2Homo sapiens (human)
retinol metabolic processCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A2Homo sapiens (human)
cellular respirationCytochrome P450 1A2Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 1A2Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A2Homo sapiens (human)
oxidative demethylationCytochrome P450 1A2Homo sapiens (human)
cellular response to cadmium ionCytochrome P450 1A2Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (17)

Processvia Protein(s)Taxonomy
hormone activityTransthyretinHomo sapiens (human)
protein bindingTransthyretinHomo sapiens (human)
identical protein bindingTransthyretinHomo sapiens (human)
thyroid hormone bindingTransthyretinHomo sapiens (human)
monooxygenase activityCytochrome P450 1A2Homo sapiens (human)
iron ion bindingCytochrome P450 1A2Homo sapiens (human)
protein bindingCytochrome P450 1A2Homo sapiens (human)
electron transfer activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1A2Homo sapiens (human)
enzyme bindingCytochrome P450 1A2Homo sapiens (human)
heme bindingCytochrome P450 1A2Homo sapiens (human)
demethylase activityCytochrome P450 1A2Homo sapiens (human)
caffeine oxidase activityCytochrome P450 1A2Homo sapiens (human)
aromatase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
extracellular regionTransthyretinHomo sapiens (human)
extracellular spaceTransthyretinHomo sapiens (human)
azurophil granule lumenTransthyretinHomo sapiens (human)
extracellular exosomeTransthyretinHomo sapiens (human)
extracellular spaceTransthyretinHomo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (21)

Assay IDTitleYearJournalArticle
AID241334Inhibitory concentration against recombinant human cytochrome P450 1A22005Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors.
AID161427Relative binding affinity to prealbumin was determined from the competition binding assays and is expressed relative to L-T41986Journal of medicinal chemistry, May, Volume: 29, Issue:5
Structurally specific binding of halogenated biphenyls to thyroxine transport protein.
AID1331301n-Octanol/water partition coefficient, log P of the compound by HPLC method
AID210553Relative binding affinity was determined by using nuclear receptor from rat liver with respect to thyroxine (T4) as KA(comp)/KA(T4) using competitive binding experiment; a = no binding1987Journal of medicinal chemistry, Jan, Volume: 30, Issue:1
Polychlorinated biphenyls and related compound interactions with specific binding sites for thyroxine in rat liver nuclear extracts.
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
AID1486518Inhibition of acid-induced wild type transthyretin (unknown origin) aggregation expressed in Escherichia coli pre-incubated for 30 mins before acid addition and further incubated for 72 hrs at 37 degC under dark conditions by UV-Vis spectrophotometry2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
AID161430Displacement of [125I]thyroxin from human plasma prealbumin.1986Journal of medicinal chemistry, Dec, Volume: 29, Issue:12
A theoretical study of the binding of polychlorinated biphenyls (PCBs), dibenzodioxins, and dibenzofuran to human plasma prealbumin.
AID288185Permeability coefficient through artificial membrane in presence of stirred water layer2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
AID288191Membrane retention in permeability experiment with artificial membrane2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID288192Partition coefficient, log P of the compound2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID1486519Binding affinity to transthyretin in human blood plasma assessed as plasma binding selectivity by measuring stoichiometry of small molecule bound to TTR incubated for 24 hrs at 37 degC by RP-HPLC2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
AID161436Relative binding affinity was determined for thyroxin binding prealbumin (TBPA) from rat liver with respect to thyroxine (T4) as KA(comp)/KA(T4) using competitive binding experiment; a = no binding1987Journal of medicinal chemistry, Jan, Volume: 30, Issue:1
Polychlorinated biphenyls and related compound interactions with specific binding sites for thyroxine in rat liver nuclear extracts.
AID161432Thyroxine binding constant on human plasma prealbumin; No binding1986Journal of medicinal chemistry, Dec, Volume: 29, Issue:12
A theoretical study of the binding of polychlorinated biphenyls (PCBs), dibenzodioxins, and dibenzofuran to human plasma prealbumin.
AID288184Permeability coefficient through artificial membrane in presence of unstirred water layer by PAMPA2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID1825839Inhibition of Streptococcus pyogenes Cas9-induced Escherichia coli killing assessed as increase in cell viability
AID161428Concentration at which 50% total binding against prealbumin protein occurs1986Journal of medicinal chemistry, May, Volume: 29, Issue:5
Structurally specific binding of halogenated biphenyls to thyroxine transport protein.
AID23673Partition coefficient (logP)2002Bioorganic & medicinal chemistry letters, Apr-08, Volume: 12, Issue:7
Novel estimation of lipophilic behaviour of polychlorinated biphenyls.
AID644414Lipophilicity, log D of the compound in octanol-water at pH 7.4 by reverse-phase HPLC analysis2012Bioorganic & medicinal chemistry, Feb-15, Volume: 20, Issue:4
QSAR study and synthesis of new phenyltropanes as ligands of the dopamine transporter (DAT).
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID1331300Lipophilicity, log D of the compound at pH 7.4 by HPLC method
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,220)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990423 (34.67)18.7374
1990's58 (4.75)18.2507
2000's165 (13.52)29.6817
2010's317 (25.98)24.3611
2020's257 (21.07)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 67.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index67.65 (24.57)
Research Supply Index7.15 (2.92)
Research Growth Index4.95 (4.65)
Search Engine Demand Index118.19 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (67.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.08%)5.53%
Reviews18 (1.41%)6.00%
Case Studies3 (0.24%)4.05%
Observational0 (0.00%)0.25%
Other1,251 (98.27%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]